Levetiracetam Teva

Levetiracetam, the active ingredient in Levetiracetam Teva, is an anticonvulsant presented as a tablet for oral use. It is used to treat various seizure types in patients with epilepsy. GNH USA supplies Levetiracetam Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication that modulates neuronal excitability to control seizures. - Partial seizures: reduces frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: decreases sudden muscle jerks. - Epilepsy (overall): contributes to overall seizure control across multiple seizure types.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or imbalance. - Headache: mild to moderate cranial pain. - Irritability: increased mood swings or agitation. - Nausea: feeling of stomach upset or urge to vomit. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or severe anxiety. - Blood disorders: low white blood cells or platelets. - Liver dysfunction: jaundice or elevated liver enzymes. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Patients and healthcare providers should consider several safety measures when using Levetiracetam. - Renal impairment: adjust dose or monitor renal function. - Psychiatric history: monitor for mood changes or suicidal ideation. - Pregnancy: discuss potential risks with a healthcare professional. - Breastfeeding: evaluate benefits versus potential infant exposure. - Concomitant CNS depressants: use caution as additive sedation may occur. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and direct sunlight.

Levetiracetam may interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Sedatives (e.g., benzodiazepines): may increase central nervous system depression. - Antidepressants (e.g., SSRIs): monitor for mood alterations. - Immunosuppressants (e.g., cyclosporine): observe for potential pharmacokinetic changes. - Hormonal contraceptives: efficacy generally unchanged, but advise standard precautions.